Curocell Inc. (KOSDAQ: 372320)

Market Cap	396.64B
Revenue	n/a
Net Income	n/a
Shares Out	14.09M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,500
Open	28,600
Previous Close	28,050
Day's Range	28,050 - 28,650
52-Week Range	18,200 - 43,000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Curocell

Curocell Inc. develops CAR-T cell therapy for the treatment of cancer. It focuses on the development of CD19 CAR-T for the treatment of lymphoma; and BCMA CAR-T for the treatment of multiple myeloma. The company was incorporated in 2016 and is based in Daejeon, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 372320